 | • レポートコード：QYR9N7787 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、ペプチドベースの胃腸障害治療薬のグローバル市場について調査・分析したレポートで、種類別（テドグルタイド、リナクロチド、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・ペプチドベースの胃腸障害治療薬の世界市場規模 ・主要企業別市場シェア ・ペプチドベースの胃腸障害治療薬の世界市場規模：種類別（テドグルタイド、リナクロチド、その他） ・ペプチドベースの胃腸障害治療薬の世界市場規模：用途別（病院薬局、小売薬局、オンライン薬局） ・ペプチドベースの胃腸障害治療薬のアメリカ市場規模（種類別、用途別） ・ペプチドベースの胃腸障害治療薬のヨーロッパ市場規模（種類別、用途別） ・ペプチドベースの胃腸障害治療薬の中国市場規模（種類別、用途別） ・ペプチドベースの胃腸障害治療薬の日本市場規模（種類別、用途別） ・ペプチドベースの胃腸障害治療薬の東南アジア市場規模（種類別、用途別） ・ペプチドベースの胃腸障害治療薬のインド市場規模（種類別、用途別） ・ペプチドベースの胃腸障害治療薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・ペプチドベースの胃腸障害治療薬の世界市場予測（2019年-2025年） ・ペプチドベースの胃腸障害治療薬の地域別市場予測（2019年-2025年） ... |
Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas.In 2018, the global Peptide Based Gastrointestinal Disorders Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Peptide Based Gastrointestinal Disorders Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Peptide Based Gastrointestinal Disorders Therapeutics development in United States, Europe and China.
The key players covered in this study
Shire
Ironwood Pharmaceuticals
Astellas Pharma
Allergan
Takeda Pharmaceutical
…
Market segment by Type, the product can be split into
Teduglutide
Linaclotide
Others
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Peptide Based Gastrointestinal Disorders Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Peptide Based Gastrointestinal Disorders Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Peptide Based Gastrointestinal Disorders Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Teduglutide
1.4.3 Linaclotide
1.4.4 Others
1.5 Market by Application
1.5.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Peptide Based Gastrointestinal Disorders Therapeutics Market Size
2.2 Peptide Based Gastrointestinal Disorders Therapeutics Growth Trends by Regions
2.2.1 Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Regions (2014-2025)
2.2.2 Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Manufacturers
3.1.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players Head office and Area Served
3.3 Key Players Peptide Based Gastrointestinal Disorders Therapeutics Product/Solution/Service
3.4 Date of Enter into Peptide Based Gastrointestinal Disorders Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2014-2019)
4.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2014-2019)
5.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in United States
5.3 United States Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
5.4 United States Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application
6 Europe
6.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2014-2019)
6.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Europe
6.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
6.4 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application
7 China
7.1 China Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2014-2019)
7.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in China
7.3 China Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
7.4 China Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application
8 Japan
8.1 Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2014-2019)
8.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Japan
8.3 Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
8.4 Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2014-2019)
9.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
9.4 Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application
10 India
10.1 India Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2014-2019)
10.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in India
10.3 India Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
10.4 India Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2014-2019)
11.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Central & South America
11.3 Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
11.4 Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application
12 International Players Profiles
12.1 Shire
12.1.1 Shire Company Details
12.1.2 Company Description and Business Overview
12.1.3 Peptide Based Gastrointestinal Disorders Therapeutics Introduction
12.1.4 Shire Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)
12.1.5 Shire Recent Development
12.2 Ironwood Pharmaceuticals
12.2.1 Ironwood Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Peptide Based Gastrointestinal Disorders Therapeutics Introduction
12.2.4 Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)
12.2.5 Ironwood Pharmaceuticals Recent Development
12.3 Astellas Pharma
12.3.1 Astellas Pharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Peptide Based Gastrointestinal Disorders Therapeutics Introduction
12.3.4 Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)
12.3.5 Astellas Pharma Recent Development
12.4 Allergan
12.4.1 Allergan Company Details
12.4.2 Company Description and Business Overview
12.4.3 Peptide Based Gastrointestinal Disorders Therapeutics Introduction
12.4.4 Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)
12.4.5 Allergan Recent Development
12.5 Takeda Pharmaceutical
12.5.1 Takeda Pharmaceutical Company Details
12.5.2 Company Description and Business Overview
12.5.3 Peptide Based Gastrointestinal Disorders Therapeutics Introduction
12.5.4 Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)
12.5.5 Takeda Pharmaceutical Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Peptide Based Gastrointestinal Disorders Therapeutics Key Market Segments
Table Key Players Peptide Based Gastrointestinal Disorders Therapeutics Covered
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Market Share by Type 2014-2025
Figure Teduglutide Figures
Table Key Players of Teduglutide
Figure Linaclotide Figures
Table Key Players of Linaclotide
Figure Others Figures
Table Key Players of Others
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Peptide Based Gastrointestinal Disorders Therapeutics Report Years Considered
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Regions 2014-2019
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Regions 2014-2019
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Manufacturers in 2018
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Peptide Based Gastrointestinal Disorders Therapeutics Product/Solution/Service
Table Date of Enter into Peptide Based Gastrointestinal Disorders Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Share by Type (2014-2019)
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Share by Application (2014-2019)
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Application in 2018
Figure United States Peptide Based Gastrointestinal Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Peptide Based Gastrointestinal Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Peptide Based Gastrointestinal Disorders Therapeutics Market Share (2018-2019)
Table United States Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2014-2019)
Table United States Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2014-2019)
Figure Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Peptide Based Gastrointestinal Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Peptide Based Gastrointestinal Disorders Therapeutics Market Share (2018-2019)
Table Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2014-2019)
Table Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2014-2019)
Figure China Peptide Based Gastrointestinal Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Peptide Based Gastrointestinal Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Peptide Based Gastrointestinal Disorders Therapeutics Market Share (2018-2019)
Table China Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2014-2019)
Table China Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2014-2019)
Figure Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Peptide Based Gastrointestinal Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Peptide Based Gastrointestinal Disorders Therapeutics Market Share (2018-2019)
Table Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2014-2019)
Table Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Peptide Based Gastrointestinal Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Peptide Based Gastrointestinal Disorders Therapeutics Market Share (2018-2019)
Table Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2014-2019)
Figure India Peptide Based Gastrointestinal Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Peptide Based Gastrointestinal Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Peptide Based Gastrointestinal Disorders Therapeutics Market Share (2018-2019)
Table India Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2014-2019)
Table India Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Peptide Based Gastrointestinal Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Peptide Based Gastrointestinal Disorders Therapeutics Market Share (2018-2019)
Table Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2014-2019)
Table Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2014-2019)
Table Shire Company Details
Table Shire Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019) (Million US$)
Figure Shire Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)
Table Shire Recent Development
Table Ironwood Pharmaceuticals Company Details
Table Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Ironwood Pharmaceuticals Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)
Table Ironwood Pharmaceuticals Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)
Table Astellas Pharma Recent Development
Table Allergan Company Details
Table Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)
Table Allergan Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Takeda Pharmaceutical Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Share by Regions in 2025
Figure United States Peptide Based Gastrointestinal Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Peptide Based Gastrointestinal Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Peptide Based Gastrointestinal Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Product (2019-2025)
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Product in 2025
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2019-2025)
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のペプチドベースの代謝障害治療薬市場：市場規模・現状・予測 A metabolic disorder can happen when abnormal chemical reactions in the body alter the normal metabolic process. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive. Peptide therapeutics are used to treat metabolic disorders owing to their stability, effici…- 世界のペプチドベースのがん治療薬市場：市場規模・現状・予測 Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer.In 2018, the global Peptide Based Cancer Therapeutics market size was…
- 世界の核酸ベースの治療薬市場：市場規模・現状・予測 Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of…
- 世界の前頭側頭障害の治療市場：市場規模・現状・予測 In 2018, the global Frontotemporal Disorders Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Frontotemporal Disorders Treatment status, future forecast, growth opportunity, …
- 世界のパニック障害市場：市場規模・現状・予測 Panic disorder is an anxiety disorder characterized by reoccurring unexpected panic attacks.Panic disorder is usually treated with counselling and medications. The type of counselling used is typically cognitive behavioral therapy which is effective in more than half of people. Medications used incl…